In mice, the Fas/Fas ligand (FasL) system has been shown to be involved in germ cell apoptosis. In the present study we evaluated the expression of 
biopsies with postmeiotic germ cell arrest compared to 10 normal testis biopsies (mean, 3.82 Ϯ 0.45 vs. 2.02 Ϯ 0.29; P ϭ 0.0001), but not in 10 biopsies with meiotic germ cell arrest (mean, 1.56 Ϯ 1.07). Fas and FasL proteins were not expressed in cases of idiopathic hypogonadotropic hypogonadism. Together, these findings may suggest that Fas/FasL expression in the human testis is developmentally regulated and under gonadotropin control. The increased germ cell expression of Fas in patients with postmeiotic germ cell arrest suggests that the Fas/FasL system may be involved in the quality control mechanism of the produced gametes. S PERMATOGENESIS is a dynamic and rather complex process, which includes proliferation and differentiation of germ cells. As observed in the majority of proliferating and differentiating tissues and also during spermatogenesis, a considerable number of germ cells, especially during the first spermatogenetic wave, die by apoptosis throughout their development (1) (2) (3) (4) . Although we still know very little about the cause(s) of germ cell death during spermatogenesis, it is suggested to serve to adjust the number of proliferating germ cells to that of the supporting Sertoli cells and to ensure a quality control of the gametes produced (2, 5, 6) . In addition, apoptosis of germ cells may be induced by a variety of conditions, including gonadotropin or growth factor withdrawal, irradiation, exposure to toxic or chemotherapeutic compounds, and cryptorchidism (7) (8) (9) (10) (11) (12) (13) (14) . In this context, a renewed attention to the cellular mechanism(s) underlying germ cell apoptosis has recently arisen by the identification of Fas ligand (FasL; CD95L) expression in the male gonad (15) (16) (17) (18) .
FasL is a type II membrane-bound protein that belongs to the tumor necrosis factor (TNF) family and is capable of inducing apoptosis in Fas-bearing cells (15, 19) . Fas (APO-1, CD95) is a transmembrane receptor protein that shares high homology with members of tumor necrosis factor/nerve growth factor receptor family. It contains an intracellular domain, called the death domain, which is responsible for the activation of multiple intracellular signaling pathways after Fas interaction with FasL or Fas receptor cross-linking (20 -22) . The physiological importance of the Fas/FasL system is underscored in lpr (lymphoproliferation) and gld (generalized lymphoproliferative disease) mice, characterized by mutations, respectively, in Fas and FasL genes (23, 24) that determine a dramatic lymphoproliferation and systemic autoimmunity due to altered lymphocyte apoptosis.
Within the mammalian testis, FasL expressed by Sertoli cells (15, 25) has proven to be a major determinant in maintaining the immune privilege of the male gonadal tissue (16, 17) . However, a functional role for the Sertoli cell-expressed FasL in inducing apoptosis of Fas-expressing germ cells has been recently demonstrated (26, 27) . Indeed, Lee and colleagues demonstrated the involvement of the Fas system in germ cell apoptosis of rat testis occurring either physiologically or after different testicular injury, such as radiation exposure or administration of Sertoli cells toxicants (26, 27) . Recent studies have shown that in the human testis also, programmed germ cell death by apoptosis is a conspicuous event during spermatogenesis (28 -32) , but the possible involvement of Fas-FasL interaction in the regulation of this event is undefined (33) (34) (35) . Recently, Pentikainen and colleagues (35) documented the expression of Fas protein by Western blot in senescent human testis. The same researchers, by means of immunohistochemistry experiments performed on isolated seminiferous tubules, showed a diffuse expression of Fas protein in cells identified as primary spermatocytes and round spermatids after apoptosis induction, whereas no information on Fas expression in normal or control conditions was provided.
In the present study, by means of RT-PCR in solution, in situ RT-PCR, and immunohistochemistry we have investigated the differential expression of Fas and FasL genes in human fetal and normal adult testis as well as in some selected human testicular pathologies. In the adult testis Fas is expressed by scattered degenerating germ cells, and FasL is highly expressed by Sertoli cells, suggesting that in humans also, the Fas-FasL interaction might be involved in the paracrine signaling between Sertoli cells and germ cells. Fas and its natural ligand are not expressed in fetal testes between 20 and 22 weeks gestation or in cases of idiopathic hypogonadotropic hypogonadism, thus suggesting that the expression of the Fas system in the human testis may be developmentally regulated and under the control of gonadotropins.
Materials and Methods Materials
Proteinase K and deoxyribonuclease (DNase), ribonuclease (RNase) free, were purchased from Sigma (Milan, Italy). First strand complementary DNA (cDNA) synthesis kit and 10 mmol/L solutions of deoxy (d)-ATP, dCTP, dGTP, and dTTP were purchased from Amersham Pharmacia Biotech (Milan, Italy). Human FasL, Fas, and ␤-actin primers were obtained from Labtek (Milan, Italy). Taq DNA polymerase, silanecoated glass slides, Amplicover discs, and clips were purchased from Perkin-Elmer Corp. 
Testicular specimens
The investigation was approved by the local institutional review board for human research.
Fetuses. Testes were collected from three fetuses (20, 21 , and 22 weeks gestation), obtained during therapeutic interruption of pregnancy due to maternal illness. Fetuses were carefully removed from the uterine cavity and immediately dissected, and one testis was snap-frozen in liquid nitrogen and stored at Ϫ80 C. The other testis of each fetus was in part fixed in Bouin's solution and in part fixed in 4% paraformaldehyde for 6 -8 h and processed for routine paraffin embedding.
Adults. Normal testis tissue was obtained from 2 fertile men, aged 35 and 47 yr, undergoing orchidectomy as treatment for testicular seminoma. A piece of each testis was immediately snap-frozen in liquid nitrogen and stored at Ϫ80 C. Adjacent parts of tissue were fixed, respectively, in Bouin's solutio, and 4% paraformaldehyde for 6 -8 h before processing for paraffin embedding. To analyze the FasL/Fas system by immunohistochemistry in cases of deranged spermatogenesis, archived testicular specimens fixed in Bouin's solution and embedded in paraffin were obtained using an open testicular biopsy technique from men with azoospermia or severe oligozoospermia (mean age Ϯ sd, 33.7 Ϯ 4.5 yr). Informed consent was obtained from all subjects. On the basis of standard qualitative interpretations of hematoxylin-and eosin-stained sections, biopsies were classified as described below: complete Sertoli cell-only syndrome (SCO; n ϭ 10): all seminiferous tubules showed only Sertoli cells; mixed atrophy, including 4 cases of Klinefelter's syndrome according to results of genetic evaluation (n ϭ 10): the tubules showed a thickened lamina propria associated with a total lack of the seminiferous epithelium (tubule shadow); this coexisted with some tubules with Sertoli cells only, and some tubules with spermatogenesis progressing through rare elongated spermatids; complete meiotic germ cell arrest (n ϭ 10): all tubules showed arrested spermatogenesis at the level of primary spermatocytes; postmeiotic germ cell arrest (n ϭ 10): almost all tubules showed spermatogenesis progressing through elongated spermatids; the latter, however, were greatly reduced to less than 5 in each cross-section of seminiferous tubules; and normal spermatogenesis (n ϭ 10): almost all tubules showed the development of more than 10 elongating spermatids in each tubule cross-section. Testicular specimens of 3 adult men, 28, 32, and 35 yr of age, affected by idiopathic hypogonadotropic hypogonadism were also included. According to the clinical records, the diagnosis was based on the lack of increase in serum gonadotropin levels over the basal levels after iv injection of 100 g GnRH (LHRH, Serono, Milan, Italy), performed after the age of 18 yr.
RNA isolation and analysis
Total cellular RNA was extracted from fetal and adult human testis using the acid guanidinium thiocyanate-phenol-chloroform method (36) . The purity and integrity of the RNA were checked spectroscopically and by gel electrophoresis before carrying out the analytical procedures. Levels of Fas and FasL messenger RNA (mRNA) were determined by the semiquantitative RT-PCR method. Two micrograms of total RNA were reverse transcribed, using the First Strand cDNA synthesis kit from Amersham Pharmacia Biotech. The cDNAs obtained were used as a template for the subsequent PCR coamplification of human (h) FasL (478 bp) and h␤-actin (287 bp) as internal control or for coamplification of hFas (427 bp) and h␤-actin (287 bp). The following primers were used: hFasL: upstream, 5Ј-GAAGGAGCTGGCAGAACTCCGAG-3Ј; and downstream, 5Ј-GACCAGAGAGAGCTCAGATACGTTGAC-3Ј; hFas: upstream, 5Ј-CCAAGTGACTGACATCAACTC-3Ј; and downstream, 5Ј-CTCTTTGCACTTGGTGTTGCTGG-3Ј; and h␤-actin: upstream, 5Ј-AGCGGGAAATCGTGCGTG-3Ј; and downstream, 5Ј-CAGGGTACAT-GGTGGTGCC-3Ј (37-39). Conditions for coamplification for hFasL and h␤-actin were 94 C for 1 min, 62 C for 1 min, and 72 C for 1 min for 35 cycles for hFasL and 25 cycles for h␤-actin. Conditions for coamplification for hFas and h␤-actin were 94 C for 1 min, 60 C for 1 min, and 72 C for 1 min for 35 cycles for hFas and 25 cycles for h␤-actin. In these conditions preliminary experiments demonstrated that the plateaus for the ␤-actin, Fas, and FasL amplification were not reached. Controls for DNA contamination or PCR carryover were performed omitting the reverse transcriptase or the RNA during RT. cDNAs were amplified using a DNA thermal cycler (Perkin-Elmer Corp.-PCR system 9700) and the Taq DNA polymerase (2 U/tube) with 15 pmol of both upstream and downstream primers and 2.2 mmol/L magnesium chloride in a final volume of 50 L. For each sample 18 L PCR amplification product were analyzed on 2% agarose gel and stained with ethidium bromide. A standard DNA molecular weight ladder (Ladder VI, Boehringer) was run to provide appropriate size markers. To monitor the specificity of the RT-PCR product, the amplified DNA was recovered from the agarose gel, purified, and subjected to sequencing reactions in the presence of fluorescent-labeled nucleotides. Samples were then analyzed by ABI Prism DNA sequencer (Perkin-Elmer Corp.). The sequences obtained all corresponded to the expected ones.
In situ RT-PCR
Fas and FasL distribution within the human fetal and adult testis was investigated by in situ RT-PCR (40, 41) . Sections of 5 m from paraformaldehyde-fixed paraffin-embedded fetal and normal adult human testis were placed on silane-coated in situ PCR glass slides (Perkin-Elmer Corp.) and incubated at 50 -60 C for 36 -48 h to ensure maximum adhesion to the slides. After heating, sections were dewaxed in xylene for 10 min three times, then immersed in fresh 100% ethanol, rehydrated in 70% ethanol and dH 2 O (RNase free), washed in phosphate-buffered saline (PBS), and permeabilized with 1 g/mL proteinase K for 10 min at room temperature. After dehydration in ethanol 70 -100% and air drying, sections were incubated in 1 IU/mL DNase (RNase free) in buffer B1 [40 mmol/L Tris-HCl (pH 7.4), 6 mmol/L MgCl 2 , and 2 mmol/L CaCl 2 ], for 18 h in a moist chamber at 37 C. The next day, sections were dehydrated in 70 -100% ethanol, air-dried, and incubated for 1 h at 42 C in moist chamber for RT. In the positive control section, treatment with DNase was omitted, whereas in both positive and negative control sections, the reverse transcriptase was omitted. The cDNA obtained was amplified in a thermal cycler in the presence of hFas, hFasL, or h␤-actin downstream and upstream primers using digoxigenin-labeled dNTPs. Conditions for amplifications were 95 C for 1 min, 60 C for 1 min, and 72 C for 1 min for 30 cycles. After PCR, sections were washed twice in PBS, left in 1% BSA in PBS for 15 min, and incubated with anti-digoxigenin alkaline phosphatase conjugate (1:250) for 1 h at room temperature. After two washings in PBS for 10 min each time, sections were incubated for 5 min in the dark in the presence of nitro blue tetrazolium salt/5-bromo-4-chloro-3-indolyl phosphate, which produces, through the enzyme-catalyzed reaction, an insoluble blue precipitate. Slides were mounted with a mounting medium and observed under the microscope.
Immunohistochemistry
Five-micron-thick tissue sections were deparaffinized, and then subjected to immunohistochemical labeling according to the following protocol. 1) Endogenous peroxidase activity was eliminated by treating sections with 0.3% H 2 0 2 in PBS for 30 min at room temperature. 2) Nonspecific binding sites were blocked by incubation for 1 h in 5% normal goat serum in PBS. 3) Sections were incubated overnight at 4 C in PBS containing the anti-FasL and Fas antibodies at a concentration of 1 g/mL. 4) After repeated washing in PBS, the immunoreaction was detected by an avidin-biotin peroxidase complex method using a biotinylated goat antirabbit or antimouse IgG (ImmunoPure ABC Peroxidase Rabbit or Mouse IgG Staining Kit). Sections were left unstained or were counterstained in hematoxylin, mounted with a mounting medium (Histovitrex, Carlo Erba, Milan, Italy), and visualized in a Leitz photomicroscope (Rockleigh, NJ). Controls were performed by omission of the primary antibody or by incubating slides with the first antibody in the presence of inhibitor peptides (2 g/mL). In a preliminary study, the different antibodies were tested with paraffin-embedded testicular tissue fixed with different fixatives and also with frozen tissue sections fixed in acetone before immunostaining. Bouin's fixative and paraffin embedding gave results comparable to those obtained with frozen, acetone-fixed sections, and it was therefore selected for the study, because it allowed a large number of archived paraffin-embedded specimens to be evaluated.
Quantitative evaluation of Fas-positive germ cells
Counts of Fas-positive germ cells were performed on slides lightly counterstained in hematoxylin and examined with a ϫ63 oil immersion objective lens and a ϫ12.5 eyepiece. S.F. performed counting on coded slides. The counting method was similar to that proposed by Rowley and Heller (42) . Longitudinal sections and cross-sections of tubules with clear lumen were used for scoring. Approximately 30 seminiferous tubules were scored in each biopsy; the total number of Fas-positive germ cells was divided by the total number of Sertoli cell nuclei, and the rate of positive cells was expressed as the number of Fas-positive germ cells per 100 Sertoli cell nuclei. Two hundred Sertoli cell nuclei with clear nucleolus were counted in each biopsy. Kruskal-Wallis one-way ANOVA by ranks was used to compare the number of Fas-positive germ cells per 100 Sertoli cell nuclei in 3 groups of biopsies with normal spermatogenesis (n ϭ 10), postmeiotic arrest (n ϭ 10), and complete meiotic arrest (n ϭ 10). The small sample size of the three groups suggested using nonparametric tests for data analysis. Post-hoc comparison between pairs of groups was assessed by Wilcoxon's rank sum test, with a downward adjustment of the ␣ level to compensate for multiple comparisons. To maintain the overall probability at a level of 0.05 in the 3 independent comparisons, the ␣ value was divided by 3 to obtain a comparisonwise ␣ ϭ 0.017 (0.05/3). Thus, each comparison was significant at the 0.017 level. Data analysis was performed with SAS, version 6.12, 1996 (SAS Institute, Inc., Cary, NC).
Results

Fas and FasL mRNAs expression in fetal and adult human testes
The expression of Fas and FasL in fetal and normal adult human testis was first evaluated at the mRNA level by semiquantitative RT-PCR. Figure 1 shows that Fas and FasL mRNAs are present in adult, but not fetal, human testis. The same set of primers used in the above experiments was also used for in situ RT-PCR to evaluate the distribution of both Fas and FasL mRNA expression within fetal and adult human testicular tissues. In these experiments, the fidelity of in situ mRNA amplification (Fig. 2) Fig. 2A ) and a negative control (DNase treatment, no reverse transcription; Fig. 2B ). The results obtained clearly demonstrated the presence in the adult human testis of FasL mRNA expression in both the seminiferous epithelium (Fig. 2, C and D) and the interstitial cells (Fig. 2E) . The irregular profiles of stained nuclei and their regular localization in the basal compartment of the seminiferous tubule (Fig. 2D) suggest that the cells expressing FasL mRNA in the human seminiferous epithelium are Sertoli cells. FasL mRNA was also expressed by interstitial Leydig cells, as judged by the intense staining of the nucleus of cells with a large cytoplasm and grouped in small perivascular clusters (Fig. 2E) . On the other hand, Fas mRNA expression was confined to scattered cells of the seminiferous epithelium (Fig. 2F) . The large nuclear size of most of the stained cells and the localization in the basal compartment of the seminiferous tubule suggest that Fas mRNA is expressed by primary spermatocytes (Fig. 2F) . Perinuclear staining was seldom found in cells identified as round spermatids, as judged by the small nuclear size and the localization very far from the basal lamina (Fig. 2G) . A perinuclear stain was also present in clusters of interstitial Leydig cells (Fig. 2H) . When the same experiments were repeated on fetal testis sections FIG. 1. Fas and FasL mRNA expression in fetal and adult human testis. Two micrograms of total RNA extracted from fetal or adult human testis were reverse transcribed, and cDNA was used as a template for PCR coamplification of h␤-actin (as an internal control) and hFas or hFasL as described in Materials and Methods. The data presented are representative of three similar and independent experiments.
no expression of either Fas or FasL mRNA could be observed (data not shown). However, when in situ RT-PCR on fetal testis sections was performed using h␤-actin primers, a strong positivity was observed in nearly all testicular cell types (data not shown).
Fas and FasL protein expression in fetal and adult testis with normal spermatogenesis
Immunohistochemistry demonstrated the expression of FasL and Fas in adult, but not fetal, testes of 20 -22 weeks gestation (Fig. 3, A-C) . Intense and consistent FasL staining was found in the basal compartment of the seminiferous tubules and in interstitial Leydig cells of testes with normal spermatogenesis (Fig. 3, D and E) . The positive staining in the seminiferous tubule was confined to Sertoli cells and was intense along the plasma membrane at the level of interSertoli cell junctions as well as in the basal region surrounding spermatogonia (Fig. 3F) . Fas expression was detected on occasional seminiferous tubules, where it was confined to isolated germ cells that, according to cell size and cell localization in the seminiferous epithelium, were primary spermatocytes (Fig. 3H) . In most cases Fas staining was confined to apoptotic primary spermatocytes, as judged by the typical cytoplasm and nuclear changes (43, 44) (Fig. 3, I and J) and to rare round spermatids (not shown). The mean number of immunostained germ cells per 100 Sertoli cells recorded in 10 biopsies with normal spermatogenesis was 2.02 Ϯ 0.29 (Table  1 ). An intense Fas staining was finally detected in Leydig cells. (Fig. 3K ). Staining was abolished by omitting the antibody against FasL (Fig. 3G) or Fas (not shown) or by preincubating the antibody with the inhibitory peptides (not shown).
Fas and FasL protein expression in adult testis with deranged spermatogenesis
FasL and Fas were not expressed in testes of men with idiopathic hypogonadotropic hypogonadism (Fig. 4, A-C) , whereas an intense immunostaining for both proteins was observed in primary hypogonadism (Fig. 4, D-H) . A diffuse immunostaining for FasL was detected in the Sertoli cells and Leydig cells of testes with complete SCO syndrome (Fig. 4D) . Cases of mixed atrophy showed intense immunostaining for FasL in tubules that contained only Sertoli cells, whereas the immunoreaction disappeared in tubule shadows (Fig. 4E) . FasL was diffusely expressed in hyperplastic Leydig cells of men with Klinefelter's syndrome (Fig. 4F) . Fas protein was never detected in SCO tubules (Fig. 4G) , whereas intense immunostaining was found in Leydig cells of all cases of primary hypogonadism (Fig. 4H) . The intense coexpression of FasL and Fas in Leydig cells of normal testes as well as in cases of primary hypogonadism was never associated with the presence of apoptotic interstitial cells. This was confirmed by microscopic analysis of epon-embedded 1-mthick sections, which allows accurate identification of cellular changes associated with apoptosis (45) . Fas protein was expressed by primary degenerating spermatocytes and rare round spermatids. The variation of Fas expression in germ cells of testes with deranged spermatogenesis was quantitatively assessed in biopsies with complete meiotic arrest or postmeiotic arrest and compared to that in biopsies with normal spermatogenesis (Table 1) . A significantly increased number of Fas-positive germ cells was observed in cases of postmeiotic arrest compared with normal testis (P ϭ 0.0001, by Wilcoxon's rank sum test) and meiotic arrest of spermatogenesis (P ϭ 0.002). It is worth mentioning that there was a huge variation of rate of Fas-positive germ cells in cases of meiotic arrest (ranging from 0.42/100 Sertoli cells to 4.28/100 Sertoli cells; Table 1 ).
Discussion
In this study we examined, at both mRNA and protein levels, the expression of the Fas-FasL system in fetal and adult normal human testis as well as in testicular biopsies with deranged spermatogenesis. The difficulty of obtaining normal testicular tissue suggested using testes obtained from fertile men undergoing orchidectomy for seminomas and testes obtained from fetuses of pregnancies interrupted because of maternal illness, although this tissue may not be entirely normal. By means of semiquantitative RT-PCR in solution, in situ RT-PCR, and immunohistochemistry, we found that Fas-FasL mRNAs and proteins are expressed in adult human testis, but not in fetal testes of 20 -22 weeks gestation. Within the adult human seminiferous tubule, Fas was expressed in scattered germ cells, mainly in primary spermatocytes, whereas FasL was expressed by Sertoli cells, suggesting that in humans also, Fas-FasL interaction might be involved, as proposed in rats (26, 27) , in the paracrine signaling between Sertoli cells and germ cells. Immunohistochemistry showed that Fas protein is mostly expressed in germ cells with degenerative features such as chromatin condensation and margination, typical of apoptosis (43, 44) . The density of Fas-positive cells reported here was roughly comparable to that of apoptotic germ cells, observed in normal adult testes, as detected by DNA strand breaks (31, 32) . Therefore, a link should exist between the expression of Fas in germ cells and a prompt activation of the apoptotic pathway, as studies in vitro in both humans (35) and rats (26, 27) have also shown. The positive stain for Fas, mostly restricted maturation, by which nonviable or abnormal cells are promptly eliminated by triggering the cell death pathway when bound to FasL. The block of FasL by an antagonistic antibody is indeed associated with an inhibition of human germ cell apoptosis in in vitro studies with segments of seminiferous tubules (35) . FasL, as shown in rats (26, 27) , is expressed by Sertoli cells at both mRNA and protein levels. The diffuse expression of FasL protein in SCO tubules and the total negative staining of nearby tubule shadows observed in cases of mixed atrophy suggest that the Sertoli cell is the only source of FasL within the human seminiferous tubule, and its expression does not require germ cells. An intriguing finding was the strong positivity for FasL protein in the basal region of Sertoli cells along the inter-Sertoli cell junctions, the main component of the blood-testis barrier, which isolates germ cells committed to enter meiosis and postmeiotic maturation in a unique adluminal environment (46) . The blood-testis barrier constitutes the physical barrier between the general circulation and testicular tissue, which probably conceals antigens from the immune system and prevents effector cell access, realizing the "testicular immune privilege" (47) . FasL produced by Sertoli cells is known to maintain the immune privilege of the male gonadal tissue (16, 17) , contributing to segregate germ cells, committed to differentiate to mature spermatids, from the immune system. A major unresolved question raised in studies on the FasFasL system in the gonadal tissue is the identification of factors that regulate the expression of FasL in the Sertoli cell. Here we report that the Fas-FasL system is not expressed at both mRNA and protein levels in fetal testis between 20 and 22 weeks gestation. At this age serum levels of fetal LH and FSH are still close to the detection limit of the assay, and the serum level of CG has already declined (48) . Moreover, a negative immunostaining for both Fas and FasL was observed in cases of idiopathic hypogonadotropic hypogonadism. Both observations suggest that the expression of Fas/ FasL in human testis is developmentally regulated, and it is probably activated during puberty. This hypothesis fits and enlarges available findings on the variation in apoptosis of germ cells postnatally in male rodents and also in man. In the human testis, apoptosis of germ cells is a rare and occasional event before puberty (28) . In rodents, the initial apoptosis of germ cells occurs concurrently with maturation of Sertoli cells (10 -15 days of age) and with the first wave of spermatogenesis, whereas it declines to occasional findings in adult normal testis (1, 49 -51) . The temporary and massive burst of germ cell apoptosis restricted to the pubertal activation of spermatogenesis and the subsequent decline concurrent with an increase in efficiency of spermatogenesis have been suggested to serve to adjust the number of maturing germ cells to the supporting capacity of Sertoli cells (1, 51) . FasL expression might represent the molecular mechanism by which the Sertoli cell at puberty tunes the number of germ cells committed to give rise to mature spermatids. A potential role for FSH as a modulator of the expression of FasL by Sertoli cells is suggested by the lack of this factor in physiological and in pathologicsl conditions associated with absent gonadotropin stimulation. The induction of FasL expression might be viewed as an aspect of the maturation of Sertoli cells that is promoted by FSH (52), although a role for LH, through testosterone stimulation, should also be considered.
An unexpected finding of our study was the coexpression of Fas and FasL in Leydig cells of adult testis. Immunostaining for Fas was reported in Leydig cells of human testis (33) , but for the first time, coexpression of Fas and FasL at both mRNA and protein levels in the Leydig cell, was documented. This was not associated with the evidence of apoptotic degeneration of Leydig cell, suggesting that the coupling of Fas by its ligand does not transduce a death signal in this cell type. Coexpression of Fas and FasL has been described in different human cells. In endometrial glandular cells, the coexpression of both molecules does not trigger apoptosis that is indeed inhibited by the antiapoptotic factor Bcl-2 (53). Normal thyreocytes constitutively express FasL (54) and Fas receptor (55) , but the induction of apoptosis through the Fas pathway is blocked by a labile protein inhibitor (55) . Therefore, the coexpression of Fas receptor and its ligand is not a rare occurrence, and it is not necessarily associated with an activation of the intracellular death signal. It is interesting that in vivo treatment of rats with a Leydig cell toxicant, ethane 1,2-dimethanesulfonate, is followed by a quick, massive death of Leydig cells by apoptosis; this is not associated with a concurrent increase in the expression of Fas protein, as detected by Western blot (56) . It is possible that under normal conditions apoptosis of Leydig cells is inhibited by an antiapoptotic factor downstream from the engagement of Fas by FasL, which is quickly released by a toxic insult.
In conclusion, this study showed that Fas/FasL is expressed in adult human testes at both mRNA and protein levels. The expression seems to be developmentally regulated and gonadotropin dependent, as it is not present in fetal testes between 20 and 22 weeks gestation or in testes of individuals affected by hypogonadotropic hypogonadism. In the seminiferous tubule, FasL is expressed by Sertoli cells, whereas Fas is expressed only by degenerating spermatocytes, and the number of Fas-positive germ cells is increased in conditions of reduced efficiency of spermatogenesis. This suggests that the Fas/FasL interaction is a component of the paracrine signaling between Sertoli cells and germ cells, which contributes to promptly eliminate abnormal germ cells already committed to accomplish differentiation to gametes.
